Craft

Pharmaron

Stock Price

¥28.1

2023-09-20

Market Capitalization

¥45.4 B

2023-09-20

Revenue

¥10.2 B

FY, 2022

Pharmaron Summary

Company Summary

Overview
Pharmaron (康龙化成) is a company operating as a contract research organization that supports the life science industry. It provides customers with pharmaceutical research and development services. The company specializes in synthetic, medicinal, and analytical chemistry, biology, pharmacology, drug safety assessment, etc.
Type
Public
Status
Active
Founded
2004
HQ
Beijing, CN | view all locations
Website
https://www.pharmaron.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Boliang Lou
  • Larry Lou
  • Bei Zheng

    Bei Zheng, Executive Vice President

    • Hua Yang

      Hua Yang, Chief Scientific Officer

    Operating MetricsView all

    Projects (CMC Services)

    463

    H1, 2020

    Preclinical Projects (CMC Services)

    292

    H1, 2020

    Phase I Clinical Projects (CMC Services)

    54

    FY, 2019

    LocationsView all

    19 locations detected

    • Beijing, Bei Jing Shi HQ

      China

      6 Taihe Road, BDA

    • Baltimore, MD

      United States

      800 West Baltimore Street

    • Exton, PA

      United States

      436 Creamery Way, Suite 600

    • Germantown, MD

      United States

      20340 Seneca Meadows Parkway

    • Louisville, KY

      United States

      201 E Jefferson St

    • Medford, MA

      United States

      47 Hall St

    and 13 others

    Pharmaron Financials

    Summary Financials

    Revenue (Q1, 2023)
    ¥2.7B
    Gross profit (Q1, 2023)
    ¥958.0M
    Net income (Q1, 2023)
    ¥350.1M
    Cash (Q2, 2023)
    ¥2.5B
    EBIT (Q1, 2023)
    ¥449.2M
    Enterprise value
    $36.7B

    Footer menu